Can a single spinal injection transform Post-Surgery pain relief?

NCT ID NCT07777627

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether a single injection of morphine or dexmedetomidine into the spinal fluid, given at the end of spine fixation surgery, can provide better pain relief than a placebo. Adults aged 21 to 60 scheduled for elective lumbar spine surgery will be randomly assigned to one of the three groups. The study measures how long patients go before needing extra pain medication, along with heart rate and blood pressure changes over the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Intrathecal morphine or intrathecal dexmedetomidine, given as a single injection into the spinal fluid at the end of surgery
What this could lead to
If one of these spinal painkillers works better, it could point to a safer, more effective way to manage pain after spine surgery, reducing the need for strong rescue opioids.
What could go wrong
This is a small, early-stage trial, and results may not apply to everyone. Both drugs carry risks like breathing problems, low blood pressure, or nausea, and the placebo comparison helps measure the true effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRATHECAL DEXMEDETOMIDINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tanta University

    RECRUITING

    Tanta, El-Gharbia, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.